思创医惠
(300078)
| 流通市值：37.63亿 | | | 总市值：37.78亿 |
| 流通股本：11.13亿 | | | 总股本：11.18亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 492,649,508.87 | 1,045,967,035.4 | 439,934,835.34 | 415,200,644.88 |
| 结算备付金 | - | - | - | 0 |
| 拆出资金 | - | - | - | 0 |
| 交易性金融资产 | 53,602,850.48 | 4,212,086.68 | 3,874,236.96 | 205,704,709.66 |
| 衍生金融资产 | - | - | - | 0 |
| 应收票据及应收账款 | 82,076,433.03 | 347,345,995.95 | 354,085,623.95 | 395,770,579.02 |
| 其中：应收票据 | - | 290,724 | 1,051,740.79 | 450,900 |
| 应收账款 | 82,076,433.03 | 347,055,271.95 | 353,033,883.16 | 395,319,679.02 |
| 应收款项融资 | 510,000 | 4,564,844 | - | 0 |
| 预付款项 | 6,683,641.55 | 11,656,959.47 | 11,163,139.31 | 11,725,710.9 |
| 应收保费 | - | - | - | 0 |
| 应收分保账款 | - | - | - | 0 |
| 应收分保合同准备金 | - | - | - | 0 |
| 其他应收款合计 | 6,661,108.28 | 51,548,748.82 | 66,222,604.4 | 42,992,233.94 |
| 存货 | 59,361,030.18 | 175,942,162.85 | 191,570,172.99 | 176,396,663.36 |
| 合同资产 | - | 37,423,187.15 | 38,468,191.73 | 40,959,637.22 |
| 一年内到期的非流动资产 | - | - | - | 0 |
| 其他流动资产 | 1,644,132.76 | 10,677,647.86 | 6,255,202.55 | 2,089,149.96 |
| 流动资产合计 | 703,188,705.15 | 1,689,338,668.18 | 1,111,574,007.23 | 1,290,839,328.94 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | - | - | - | 0 |
| 债权投资 | - | - | - | 0 |
| 其他债权投资 | - | - | - | 0 |
| 长期应收款 | - | 19,927,740.15 | 19,927,740.15 | 19,927,740.15 |
| 长期股权投资 | 72,252,216.49 | 106,010,142.11 | 103,848,078.6 | 104,540,469.97 |
| 其他权益工具投资 | - | - | - | 0 |
| 其他非流动金融资产 | 99,977,517.49 | 127,127,351.36 | 77,127,351.36 | 77,127,351.36 |
| 投资性房地产 | 13,998,884.7 | 2,104,098.97 | 2,857,182.97 | 292,351,288.6 |
| 固定资产 | 99,685,323.27 | 139,002,708.17 | 144,872,928.7 | 346,767,620.14 |
| 在建工程 | - | - | 879,115.05 | 879,115.05 |
| 生产性生物资产 | - | - | - | 0 |
| 油气资产 | - | - | - | 0 |
| 使用权资产 | 1,483,990.04 | 5,717,163.15 | 1,995,115.37 | 2,303,596.55 |
| 无形资产 | 14,005,201.43 | 28,220,421.68 | 35,227,896.8 | 45,731,505.44 |
| 开发支出 | - | - | - | 0 |
| 商誉 | - | - | - | 0 |
| 长期待摊费用 | 251,171.92 | 758,024.38 | 3,847,557.87 | 4,608,687.02 |
| 递延所得税资产 | 3,714,501.45 | 4,845,048.86 | 4,718,565.09 | 4,718,565.09 |
| 其他非流动资产 | - | - | - | 0 |
| 非流动资产合计 | 305,368,806.79 | 433,712,698.83 | 395,301,531.96 | 898,955,939.37 |
| 资产总计 | 1,008,557,511.94 | 2,123,051,367.01 | 1,506,875,539.19 | 2,189,795,268.31 |
| 流动负债: | | | | |
| 短期借款 | - | 90,075,660 | - | 0 |
| 向中央银行借款 | - | - | - | 0 |
| 吸收存款及同业存放 | - | - | - | 0 |
| 拆入资金 | - | - | - | 0 |
| 交易性金融负债 | - | - | - | 0 |
| 衍生金融负债 | - | - | - | 0 |
| 应付票据及应付账款 | 40,449,311.42 | 272,245,510.79 | 299,394,087.15 | 319,186,637.94 |
| 其中：应付票据 | - | - | - | 0 |
| 应付账款 | 40,449,311.42 | 272,245,510.79 | 299,394,087.15 | 319,186,637.94 |
| 预收款项 | - | - | - | 0 |
| 合同负债 | 9,033,144.98 | 67,158,630.94 | 64,208,706.56 | 56,886,458.05 |
| 卖出回购金融资产款 | - | - | - | 0 |
| 应付手续费及佣金 | - | - | - | 0 |
| 应付职工薪酬 | 16,116,536.98 | 31,429,789.57 | 29,946,921.03 | 31,335,368.33 |
| 应交税费 | 2,920,599.73 | 36,615,613.55 | 44,303,063.09 | 36,774,224.89 |
| 其他应付款合计 | 73,411,309.26 | 727,472,897.88 | 157,151,801.89 | 631,253,933.93 |
| 应付分保账款 | - | - | - | 0 |
| 保险合同准备金 | - | - | - | 0 |
| 代理买卖证券款 | - | - | - | 0 |
| 代理承销证券款 | - | - | - | 0 |
| 一年内到期的非流动负债 | 1,370,585.58 | 4,837,581.72 | 1,370,585.58 | 265,345,316.99 |
| 其他流动负债 | 513,569.33 | 63,463,237.37 | 62,950,874.19 | 61,801,417.21 |
| 流动负债合计 | 143,815,057.28 | 1,293,298,921.82 | 659,326,039.49 | 1,402,583,357.34 |
| 非流动负债: | | | | |
| 长期借款 | - | - | - | 0 |
| 应付债券 | - | - | - | 0 |
| 优先股 | - | - | - | 0 |
| 永续债 | - | - | - | 0 |
| 租赁负债 | 1,018,447.5 | 1,837,763.9 | 1,018,447.5 | 1,018,447.5 |
| 长期应付款 | 232,211,857.8 | 244,340,808.48 | 237,734,980.94 | 153,736,323.48 |
| 长期应付职工薪酬 | - | - | - | 0 |
| 预计负债 | 40,658,380.86 | 42,369,404.45 | 43,079,860.01 | 43,079,860.01 |
| 递延收益 | - | - | - | 0 |
| 递延所得税负债 | - | - | - | 0 |
| 其他非流动负债 | - | 514,012.58 | 514,012.58 | 514,012.58 |
| 非流动负债合计 | 273,888,686.16 | 289,061,989.41 | 282,347,301.03 | 198,348,643.57 |
| 负债合计 | 417,703,743.44 | 1,582,360,911.23 | 941,673,340.52 | 1,600,932,000.91 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,117,872,230 | 1,117,872,230 | 1,117,872,230 | 1,125,092,230 |
| 其他权益工具 | - | - | - | 0 |
| 资本公积 | 1,787,458,880.56 | 1,787,458,880.56 | 1,787,458,880.56 | 1,830,213,446.44 |
| 减:库存股 | - | - | - | 49,974,565.88 |
| 其他综合收益 | -4,701,516.1 | -3,600,583.7 | -12,637,014.24 | -7,432,479.9 |
| 专项储备 | - | - | - | 0 |
| 盈余公积 | 72,600,033.72 | 72,600,033.72 | 72,600,033.72 | 72,600,033.72 |
| 一般风险准备 | - | - | - | 0 |
| 未分配利润 | -2,395,471,893.86 | -2,442,541,206.32 | -2,410,268,730.54 | -2,390,709,729.77 |
| 归属于母公司股东权益合计 | 577,757,734.32 | 531,789,354.26 | 555,025,399.5 | 579,788,934.61 |
| 少数股东权益 | 13,096,034.18 | 8,901,101.52 | 10,176,799.17 | 9,074,332.79 |
| 股东权益合计 | 590,853,768.5 | 540,690,455.78 | 565,202,198.67 | 588,863,267.4 |
| 负债和股东权益合计 | 1,008,557,511.94 | 2,123,051,367.01 | 1,506,875,539.19 | 2,189,795,268.31 |
| 公告日期 | 2025-10-16 | 2025-08-23 | 2025-04-30 | 2025-04-30 |
| 审计意见(境内) | | | | 保留意见 |